Three-dimensional corrective exercise therapy for idiopathic scoliosis: study protocol for a prospective non-randomized trial

BMC Musculoskeletal Disorders

卷:23

Mengdie Jin¹  Xuan Zhou¹  Xiaoqing Zhu¹  Qikai Wu¹  Juping Liang¹  Xin Li¹  Qing Du¹  Haibin Guo² 

[1] Department of Rehabilitation, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University;

[2] Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;

关键词: Idiopathic scoliosis;    Three-dimensional corrective exercise;    Cobb angle;    Physical conditions;    Quality of life;   

DOI  :  10.1186/s12891-022-05057-7

来源: DOAJ

【 摘 要 】

Abstract Background Although physiotherapeutic scoliosis-specific exercises (PSSEs) with or without other conservative treatments may improve scoliotic deformities, the evidence is insufficient. Three-dimensional corrective exercises (TDCEs) for scoliosis are based on the theory of PSSEs and are characterized by a combination of outpatient treatment and home-based exercise. This study aims to evaluate the effectiveness of TDCEs for idiopathic scoliosis (IS). Methods The participants will be divided into two age- and sex-matched groups: an experimental group (EG) treated with three-dimensional corrective exercise therapy (TDCET) and a control group (CG) receiving generalized exercise therapy. In each arm, mild and moderate IS cases will be reclassified based on the Cobb angle and biopsy results. The primary endpoint is the change in the largest Cobb angle; the secondary endpoints are the sagittal index, forced vital capacity, peak oxygen uptake, and peak oxygen uptake. Sixty-six patients with mild IS and 78 patients with moderate IS will be included. Discussion This study is the first controlled trial to systematically assess the effectiveness of TDCEs for IS. In addition to TDCET including three-dimensional corrective exercises, family rehabilitation and basic body awareness therapy may help patients adopt supportive attitudes and appropriate behaviours, thus enhancing their compliance with exercises and achieving better outcomes. Trial registration The study protocol was registered at www.clinicaltrials.gov (number identifier: NCT04539522 ). Registered on August 27, 2020.

【 授权许可】

Unknown